New Delhi, Jan. 28 -- Gland Pharma, on Wednesday, posted a sharp 27.74% increase in its consolidated net profit for the third quarter of the ongoing fiscal year at Rs.261.48 crore. The company had posted a net profit of Rs.204.69 crore in the same period last year.

Its revenue from operations during the quarter under review rose 22.49% year-on-year (YoY) to Rs.1695.36 crore, according to the exchange filing shared by the company.

On the operating front, its EBITDA came in 21% YoY higher at Rs.434.9 crore from Rs.360 crore a year ago. Margins remained steady at 26% YoY but rose from 21% in the quarter ended September 2025.

In Q3 FY26, Gland Pharma recorded an exceptional item of Rs.24.34 crore, reflecting the impact of the new Labour Co...